The Link between Oral and Gut Microbiota in Inflammatory Bowel Disease and a Synopsis of Potential Salivary Biomarkers
Source abstract
Abstract
The objective of this review is to provide recent evidence for the oral–gut axis connection and to discuss gastrointestinal (GI) immune response, inflammatory bowel disease (IBD) pathogenesis, and potential salivary biomarkers for determining GI health. IBD affects an estimated 1.3% of the US adult population. While genetic predisposition and environment play a role, abnormal immune activity and microbiota dysbiosis within the gastrointestinal tract are also linked in IBD pathogenesis. It has been inferred that a reduced overall richness of bacterial species as well as colonization of opportunistic bacteria induce systemic inflammation in the GI tract. Currently, there is supporting evidence that both oral and gut microbiota may be related to the development of IBD. Despite this, there are currently no curative therapies for IBD, and diagnosis requires samples of blood, stool, and invasive diagnostic imaging techniques. Considering the relative ease of collection, emerging evidence of association with non-oral diseases may imply that saliva microbiome research may have the potential for gut diagnostic or prognostic value. This review demonstrates a link between saliva and intestinal profiles in IBD patients, suggesting that saliva sampling has the potential to serve as a non-invasive biomarker for gut diseases such as IBD in the oral–gut axis.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Gut microbiota and health · Salivary Gland Disorders and Functions · Clostridium difficile and Clostridium perfringens research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physiology & Cell Biology, School of Medicine, University of Nevada, Reno, NV 89557, USA
Department of Nutrition, University of Nevada, Reno, NV 89557, USA
School of Medicine, University of Nevada, Reno, NV 89557, USA
Environmental Sciences Graduate Program, University of Nevada, Reno, NV 89557, USA
References (100+)
Show source-provided references
1. Clinical Presentation of Crohn’s, Ulcerative Colitis, and Indeterminate Colitis: Symptoms, Extraintestinal Manifestations, and Disease Phenotypes10.1053/j.sempedsurg.2017.10.003 ↗
2. Indeterminate colitis10.1136/jcp.2003.015214 ↗
3. Inflammatory bowel disease: Clinical aspects and treatments10.2147/JIR.S65979 ↗
4. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease10.1007/s12275-018-8049-8 ↗
5. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases10.1053/j.gastro.2019.03.017 ↗
6. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci10.1038/ng.3528 ↗
7. Genetics and epigenetics of IBD10.1016/j.phrs.2020.104892 ↗
8. Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study10.1093/ecco-jcc/jjz150 ↗
9. An Update on Inflammatory Bowel Disease10.1016/j.pop.2017.07.010 ↗
10. Inflammatory bowel diseases: Time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)10.2147/JIR.S190929 ↗
11. Epidemiology and natural history of inflammatory bowel diseases10.1053/j.gastro.2011.01.055 ↗
12. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies10.1016/S0140-6736(17)32448-0 ↗
13. Human Development Index and Inflammatory Bowel Diseases10.9734/JAMMR/2018/40710 ↗
14. Statovci, D., Aguilera, M., MacSharry, J., and Melgar, S. (2017). The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces. Front. Immunol., 8.10.3389/fimmu.2017.00838 ↗
15. The gut microbiome shapes intestinal immune responses during health and disease10.1038/nri2515 ↗
16. Dysbiosis in inflammatory bowel diseases: The oxygen hypothesis10.1038/ismej.2013.80 ↗
17. Treatment of Inflammatory Bowel Disease (IBD)10.1016/S1734-1140(11)70575-8 ↗
18. Celiberto, L.S., Vallance, B.A., and Cavallini, D.C. (2020). Lactic Acid Bacteria: A Functional Approach, Taylor & Francis Group LLC.
19. Dang, X., Xu, M., and Liu, D. (2020). Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis. PLoS ONE, 15.10.1371/journal.pone.0228846 ↗
20. Fecal transplantation for treatment of inflammatory bowel disease
21. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study10.1093/ibd/izz088 ↗
22. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study
23. Diet, Microbes, and Host Genetics: The Perfect Storm in Inflammatory Bowel Diseases10.1007/s00535-013-0777-2 ↗
24. ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation10.1073/pnas.1912774117 ↗
25. Macrophages in intestinal inflammation and resolution: A potential therapeutic target in IBD10.1038/s41575-019-0172-4 ↗
26. The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases10.1155/2016/2795090 ↗
27. Intestinal barrier dysfunction in inflammatory bowel diseases10.1002/ibd.20539 ↗
28. The IL-23/IL-17 pathway in human chronic inflammatory diseases—New insight from genetics and targeted therapies10.1038/s41435-019-0067-y ↗
29. Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis10.1053/j.gastro.2019.08.043 ↗
30. The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis10.1016/j.cell.2020.05.048 ↗
31. A Frameshift Mutation in NOD2 Associated With Susceptibility to Crohn’s Disease10.1038/35079114 ↗
32. The Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod210.1021/acsinfecdis.6b00154 ↗
33. The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota10.1126/science.1206095 ↗
34. Intestinal microbiome adjusts the innate immune setpoint during colonization through negative regulation of MyD8810.1038/s41467-018-06658-4 ↗
35. LPS/TLR4 Signal Transduction Pathway10.1016/j.cyto.2008.01.006 ↗
36. Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD8810.4049/jimmunol.1402598 ↗
37. Inflammatory responses and inflammation-associated diseases in organs10.18632/oncotarget.23208 ↗
38. The Intestinal Epithelium: Central Coordinator of Mucosal Immunity10.1016/j.it.2018.04.002 ↗
39. Granger, D.A. (2020). Salivary Bioscience—Foundations of Interdisciplinary Saliva Research and Applications, Springer.10.1007/978-3-030-35784-9 ↗
40. The oral microbiota: Dynamic communities and host interactions10.1038/s41579-018-0089-x ↗
41. Intestinal Stem Cells10.1007/s11894-010-0130-3 ↗
42. Krasteva-Christ, G. (2020). Reference Module in Neuroscience and Biobehavioral Psychology. Chapter: Extraoral Taste Receptors, Elsevier Inc.10.1016/B978-0-12-809324-5.23827-3 ↗
43. Microbiota promote secretory cell determination in the intestinal epithelium by modulating host Notch signaling10.1242/dev.155317 ↗
44. Interpreting heterogeneity in intestinal tuft cell structure and function10.1172/JCI120330 ↗
45. Gut Microbial Influences on the Mammalian Intestinal Stem Cell Niche10.1155/2017/5604727 ↗
46. The Intestinal Crypt, a Prototype Stem Cell Compartment10.1016/j.cell.2013.07.004 ↗
47. The Paneth Cell: The Curator and Defender of the Immature Small Intestine10.3389/fimmu.2020.00587 ↗
48. Host–microbiota interactions in inflammatory bowel disease10.1038/s41577-019-0268-7 ↗
49. The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions10.1016/j.jcmgh.2019.07.006 ↗
50. Azzouz, L.L., and Sharma, S. (2020). Physiology, Large Intestine, StatPearls Publishing.
51. Roles of the Gel-Forming MUC2 Mucin and Its O-glycosylation in the Protection Against Colitis and Colorectal Cancer10.1248/bpb.b12-00412 ↗
52. Goblet cells: Multifaceted players in immunity at mucosal surfaces10.1038/s41385-018-0039-y ↗
53. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion10.1126/science.aaf7419 ↗
54. Watanabe, K., Itoh, K., Park, S.-H., Kaku, M., Ishii, K., Sasano, H., Naitoh, T., Unno, M., and Fukushima, K. (2020). Resistin-like Molecule Beta, a Colonic Epithelial Protein, Exhibits Antimicrobial Activity Against Staphylococcus Aureus Including Methicillin-Resistant Strains. Surg. Today.10.1007/s00595-020-01974-z ↗
55. Enteric Nervous System-Derived IL-18 Orchestrates Mucosal Barrier Immunity10.1016/j.cell.2019.12.016 ↗
56. Nakanishi, K. (2018). Unique Action of Interleukin-18 on T Cells and Other Immune Cells. Front. Immunol.10.3389/fimmu.2018.00763 ↗
57. Inflammasomes in health and disease10.1038/nature10759 ↗
58. Dual roles of IL-18 in colitis through regulation of the function and quantity of goblet cells
59. Neu, J. (2008). Gastroenterology and Nutrition: Neonatology Questions and Controversies, Elsevier.
60. Johansen, F.-E., Yen, E.H., and Dickinson, B. (2006). Physiology of the Gastrointestinal Tract (Fourth Edition). Chapter 43—Biology of Gut Immunoglobulins, Academic Press.10.1016/B978-012088394-3/50046-5 ↗
61. Slifer, Z.M., and Blikslager, A.T. (2020). The Integral Role of Tight Junction Proteins in the Repair of Injured Intestinal Epithelium. Int. J. Mol. Sci., 21.10.3390/ijms21030972 ↗
62. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction10.1136/gutjnl-2018-317726 ↗
63. Modulation of 5-fluorouracil Activation of toll-like/MyD88/NF-κB/MAPK Pathway by Saccharomyces Boulardii CNCM I-745 Probiotic10.1016/j.cyto.2019.154791 ↗
64. Intestinal IgA synthesis: Regulation of front-line body defences10.1038/nri982 ↗
65. Mechanosensing by Peyer’s patch stroma regulates lymphocyte migration and mucosal antibody responses10.1038/s41590-019-0505-z ↗
66. McGhee, J.R., and Fujihashi, K. (2012). Inside the Mucosal Immune System. PLoS Biol., 10.10.1371/journal.pbio.1001397 ↗
67. Intestinal M Cells: Tireless Samplers of Enteric Microbiota10.1111/tra.12757 ↗
68. M cells in Peyer’s patches of the intestine10.1016/S0074-7696(08)61346-7 ↗
69. Specific Microbiota Enhances Intestinal IgA Levels by Inducing TGF-β in T Follicular Helper Cells of Peyer’s Patches in Mice10.1002/eji.201948474 ↗
70. Intestinal M cells10.1093/jb/mvv121 ↗
71. Brandtzaeg, P. (2013). Secretory IgA: Designed for Anti-Microbial Defense. Front. Immunol., 4.10.3389/fimmu.2013.00222 ↗
72. Interaction between microbiota and immunity in health and disease10.1038/s41422-020-0332-7 ↗
73. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis10.1038/nri3608 ↗
74. Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.10.3390/microorganisms7010014 ↗
75. Control of Pathogens and Pathobionts by the Gut Microbiota10.1038/ni.2608 ↗
76. Pathobionts of the Gastrointestinal Microbiota and Inflammatory Disease10.1016/j.coi.2011.07.010 ↗
77. Diet rapidly and reproducibly alters the human gut microbiome10.1038/nature12820 ↗
78. Clostridium difficile infection: New developments in epidemiology and pathogenesis10.1038/nrmicro2164 ↗
79. Duodenal infusion of donor feces for recurrent Clostridium difficile10.1056/NEJMoa1205037 ↗
80. A microbial signature for Crohn’s disease10.1136/gutjnl-2016-313235 ↗
81. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses10.1038/s41564-019-0483-9 ↗
82. Oral microbiomes: More and more importance in oral cavity and whole body10.1007/s13238-018-0548-1 ↗
83. The human oral microbiome10.1128/JB.00542-10 ↗
84. The Oral Microbiota: Living with a Permanent Guest10.1089/dna.2009.0874 ↗
85. Interbacterial Adhesion Networks within Early Oral Biofilms of Single Human Hosts10.1128/AEM.00407-17 ↗
86. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray10.1902/jop.2009.090185 ↗
87. The oral microbiome in health and disease and the potential impact on personalized dental medicine10.1111/j.1601-0825.2011.01851.x ↗
88. Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response10.4049/jimmunol.1301970 ↗
89. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota10.1038/srep04828 ↗
90. The oral microbiota in colorectal cancer is distinctive and predictive10.1136/gutjnl-2017-314814 ↗
91. Child Weight Gain Trajectories Linked To Oral Microbiota Composition10.1038/s41598-018-31866-9 ↗
92. Rosier, B.T., De Jager, M., Zaura, E., and Krom, B.P. (2014). Historical and contemporary hypotheses on the development of oral diseases: Are we there yet?. Front. Cell Infect. Microbiol., 4.10.3389/fcimb.2014.00092 ↗
93. Gut microbiota in multiple sclerosis: Possible influence of immunomodulators10.1097/JIM.0000000000000192 ↗
94. Defining the normal bacterial flora of the oral cavity10.1128/JCM.43.11.5721-5732.2005 ↗
95. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis10.1002/art.38348 ↗
96. Implication of Porphyromonas gingivalis in colitis and homeostasis of intestinal epithelium10.1186/s42826-019-0029-6 ↗
97. Nakajima, M., Arimatsu, K., Kato, T., Matsuda, Y., Minagawa, T., Takahashi, N., Ohno, H., and Yamazaki, K. (2015). Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver. PLoS ONE, 10.10.1371/journal.pone.0134234 ↗
98. Oral microbiome composition changes in mouse models of colitis10.1111/jgh.12713 ↗
99. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation10.1126/science.aan4526 ↗
100. Santos, L. (2020). Intestinal microbiota regulates tryptophan metabolism following oral infection with Toxoplasma gondii—Santos—Parasite Immunology—Wiley Online Library. Parasite Immunol.